Drugs For Treating Drug Addiction Barry Zevin MD Tom Waddell Health Center San Francisco Department of Public Health Homeless Programs Board Certified.

Slides:



Advertisements
Similar presentations
Introduction to Drug Misuse Les Goldman. Objectives Gain basic knowledge of Common current patterns of drug misuse Local referral pathways Available treatments.
Advertisements

DBHDS Vision: A life of possibilities for all Virginians Treatment for Opioid Addiction Public Community Treatment in Virginia Virginia Heroin and Prescription.
Addiction A-Pharmacological approaches to treating drug dependence B-Clinical use of drugs in substance dependence.
Medication Assisted Treatment: An Introduction Deborah A. Orr, Ph.D., RN Remington College School of Nursing.
Swinomish Wellness Program
Treating Nicotine Dependence in Patients with Addictive Disorders Eric Heiligenstein, M.D. Director of Psychiatry University Health Services University.
University Hospital “Sisters of Charity” Psychiatric Clinic Vinogradska c. 29, 1000 Zagreb, Croatia Davor Moravek Addiction and psychotic.
Module 4: Interaction of. Objectives To be aware of the possible reasons why dual diagnosis occurs To be aware of the specific effects of substances on.
Sublingual Buprenorphine and Pain
Monitored Abstinence Martin H. Plawecki MD, PhD Indiana University School of Medicine Department of Psychiatry Alcohol Medical Scholars Program.
Copyright Alcohol Medical Scholars Program 1 Opioid Agonist Treatment: “Trading one substance for another?” Joseph Sakai, M.D.
Methadone in Opioid Addiction David Kan, M.D. University of California San Francisco VA Medical Center San Francisco.
® © 2013 National Safety Council Prevention: Teen Abuse of Prescription Drugs Support for this project was provided by the U.S. Department of Health and.
The Medical Model: Addiction is a Brain Disease
3-1 Lori L. Phelps California Association for Alcohol/Drug Educators, 2013.
Role of Medications in Recovery and the Prevention of Relapse Mark Publicker, MD FASAM Medical Director, Mercy Recovery Center, Westbrook Maine.
November 16, 2012Harm Reduction Conference1 Cannabis as a facilitator of mindfulness: Implications for the treatment of addiction. Amanda Reiman, PhD MSW.
Diagnosis And Treatment Of Prescription Opioid Dependence Steven W. Clay, D.O. Associate Professor, Department of Family Medicine Ohio University College.
Prison staff and harm reduction Core module session 1 Training Criminal Justice Professionals in Harm Reduction Services for Vulnerable Groups funded by.
SUBSTANCE USE DISORDERS GENERAL METHODS OF TREATMENT Inpatient Detoxification and Rehabilitation Outpatient Individual, Couple, or Family Counseling Self-help.
Psychopharmacology – A brief introduction. Objectives Review general categories of psychiatric disorders Review general categories of psychiatric disorders.
Medication Assisted Therapy for Opioid Addiction: Methadone and Buprenorphine Andrew J. Saxon, M.D. Veterans Affairs Puget Sound Health Care System and.
PSYCHOPATHOLOGY OF CHILDREN AND FAMILY
Good Prescribing to support Criminal Justice Interventions
Nicotine Holley Williamson and Rachel Martinez. Addiction Chewed, Smoked, or Inhaled Absorbed within 7 Seconds of inhalation Nicotine molecule shaped.
Drugs used in treatment of addiction
Chapter 11 Substance-Related Disorders
 Methadone is prescribed to relieve moderate to severe pain that has not been relieved by non-narcotic pain relievers.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
Drug addiction – learning gone wild? Dr Stuart McLaren MRCPsych. Phase 1 Psychopharmacology module
Tom Waddell Urban Health Clinic: Patients Using Controlled Medicines* If you are taking controlled medicines, your safety is our highest priority! Our.
Medication Assisted Treatment: “Getting it Right” Deborah Acker RN, CFN Nurse Service Administrator Division of Protection and Permanency Department for.
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
Brain diseases: Substance abuse and co-occurring disorders Mark Publicker, MD FASAM.
 2010 Cengage-Wadsworth Addictive Behavior Chapter 13.
Management of Substance Use Disorder Module P: Addiction-Focused Pharmacotherapy.
CHAPTER 12 SUBSTANCE-RELATED AND ADDICTIVE DISORDERS Copyright © 2014 McGraw-Hill Education. All rights reserved. No reproduction or distribution without.
TRANSDISCIPLINARY FOUNDATION II: TREATMENT KNOWLEDGE Contributor: Lori Phelps Lori L. Phelps California Association for Alcohol/Drug Educators, 2015 Chapter.
1 Medication Development for Treatment of Drug Dependence Donald R. Wesson, MD Consultant, CNS Medications Development Chairman, ASAM Medications Development.
What the National Institute on Drug Abuse’s Clinical Trials Network Can Do for You? Major Findings from Medication Trials and Implications for Community-Based.
Chapter 5 Drugs of Abuse Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.
After the ED Alcohol & Drug Treatment Options Dr Mark Daglish Director of Addiction Psychiatry Royal Brisbane & Women’s Hospital.
1 Use of Pharmacotherapies by Substance Abuse Treatment Facilities November 2007 Cathie E. Alderks, PhD Substance Abuse and Mental Health Services Administration.
September 2015 PHARMACOLOGY OF ADDICTIONS.  Understanding the pharmacological basis of medications used to manage dependence  Understanding how pharmacological.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
Drugs used in treatment of addiction. What is Addiction? It is well known that the initial decision to use drugs is voluntary Addiction is a chronic,
Medstat MercuryMD Micromedex PDR Solucient Substance abuse medications: Trends and prescribing patterns by physician specialty November 5, 2007 American.
Specialist service provision. Who is involved in specialist services? Statutory services –Run by NHS and Social Care, these deliver medical and psychosocial.
Michael Fishman, MD Director of Young Adult Program Talbott Recovery Challenges Facing CRC’s and Young Adults in Recovery.
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
Medication Assisted Treatment Daniel T. Brown, D.O. Medical Director, Meridian HealthCare.
Gregory S. Brigham, Ph.D., CEO
Medication Assisted Treatment
Medication-Assisted Therapy at Coleman Profession Services
Neonatal Abstinence Syndrome: An emerging issue for Part C systems?
STOP! Safe Treatment of Pain
Tae Woo PARK, MD, MSC Boston university School of medicine
SBIRT..What should I know?
MEDICATION ASSISTED TREATMENT for OPIATE ADDICTION
Substance-Related and Addictive Disorders
Medication Assisted Treatment
Medication-Assisted Treatment 101: Breaking the Stigma
ADDICTION
Medication Assisted Treatment: Changing the Trajectory of the Opioid Epidemic
Medications used in Treatment of Alcohol and Drug Use Disorders
Medication Assisted Treatment of Opioid Use Disorder
What is it? What causes it? What can we do about it?
PSYCHOPATHOLOGY OF CHILDREN AND FAMILY
Presentation transcript:

Drugs For Treating Drug Addiction Barry Zevin MD Tom Waddell Health Center San Francisco Department of Public Health Homeless Programs Board Certified Internal Medicine Board Certified Addiction Medicine

Disclosures And Disclaimer Barry Zevin accepts no payments, samples, or gifts from any pharmaceutical companies The opinions expressed here are those of the presenter All information regarding medications expressed here should be checked out!

Drugs for Treating Drug Addiction? What’s the difference between a drug and a medication anyway? If a medication could treat addiction, how would we know it was working? Why have the results of this been “disappointing” so far? Disappointing to who?

3 Flavors of Outcomes Traditional Abstinence Paradigm Neurobiology of Addiction Paradigm Harm Reduction Paradigm

What Would an Effective Medication Look Like From a Harm Reduction Point of View?

What is FDA Approved For Treating Addiction? Tobacco: nicotine replacement, bupropion, verenicline Alcohol: chlordiazapoxide (specific regimen for withdrawal), diazapam (specific regimen regimen for withdrawal), oxazapam (specific regimen regimen for withdrawal), disulfiram, acamprosate, naltrexone Opioids – heroin: naltrexone, methadone only in NTP, buprenorphine Opioids – prescription opioids: naltrexone, methadone only in NTP, buprenorphine Stimulants – methamphetamine: none Stimulants – cocaine: none Benzodiazepine, carisoprodol, GHB, Other sedative-hypnotics: none Marijuana: none Process Addictions – gambling, porno, shopping, etc.: none

FDA Approved For Indications Other Than Addiction Tobacco: clonidine, nortryptaline Alcohol: benzodiazepines, topiramate, ondansetron, valproate, other aeds, baclofen, Opioids – heroin: clonidine, other prescription opioids Opioids – prescription opioids: clonidine, other prescription opioids Stimulants – methamphetamine: baclofen, other psychostimulants, mirtazapine, bupropion, venlafaxine, topiramate, other aeds Stimulants – cocaine: baclofen, naltrexone, topiramate, other aeds Marijuana: gabapentin, pregabalin Process Addictions – gambling, porno, shopping, etc.: naltrexone

Other Non FDA Approved Substances Used to Treat Addiction Tobacco: Herbs (lobelia, St. Johns wort, oat straw, valerian, ginseng) Alcohol: cannabis Opioids – heroin: heroin, ibogaine Opioids – prescription opioids: ibogaine Stimulants – methamphetamine: cannabis Stimulants – cocaine: cannabis Marijuana: ? Process Addictions – gambling, porno, shopping, etc.: ?

Relevant Outcomes Safe / comfortable withdrawal Abstinence / relapse prevention Controlled use Reduced heavy use / Less using days / Less use overall Reduce harm related to mode of use, impurity of substance Prevent overdose Better mental health Better quality of life Reduce mortality Retention in treatment Reduce craving Anti-depressant Better cognition / Maintain cognitive function Reset tolerance Turn on or off effects of drug as needed Reduce criminal activity

What Works? Good evidence – Scientific study – Experience of practitioners and patients Relevant outcomes Reasonable safety – benefits outweigh adverse effects Acceptability to patients Acceptable cost for benefit Conversely what doesn’t work is defined by absence of evidence, irrelevant outcomes, risk, and lack of acceptability to potential patients, unavailable due to high cost

What Works? BZD treatment of alcohol withdrawal – Thiamine to prevent WKS Treatment of co-occurring mental health disorders – esp. if treatment adds additional / symptomatic benefits and has reasonable safety and acceptability – Depression treatment – Psychosis treatment – ADHD treatment – Anxiety disorders

What Works? Naloxone to reverse opioid overdose Buprenorphine, methadone maintenance to treat opioid dependence Nicotine replacement with gradual tapering to treat tobacco dependence – Nicotine patch plus short acting nicotine Nicotine replacement to reduce smoking even in people not ready to quit Bupropion or nortryptaline to treat tobacco dependence Varenicline to treat tobacco dependence

What’s Worth Trying? Less Evidence / Less Relevant Outcomes / Higher Risk / Less Acceptability Placebo for any indication Cannabis to treat various addictions Alcohol – Baclofen, various aed’s to treat alcohol withdrawal – Naltrexone for alcohol dependence – Disulfiram for alcohol dependence when there is strong family or other support for witnessed dosing – Acamprosate for alcohol dependence – Ondansetron for alcohol dependence esp in strong family history / early onset drinkers Tobacco – Nicotine replacement used indefinitely – Verenicline for patients with underlying mental health disorders (in patients who can be followed up closely)

What’s Worth Trying? Less Evidence / Less Relevant Outcomes / Higher Risk / Less Acceptability Opioids – Clonidine for Opioid withdrawal (along with various other symptomatic medications) – Naltrexone for opioid dependence (in “highly motivated”?) Stimulants – Baclofen for cocaine or methamphetamine dependence (esp if chronic pain / muscle spasm) – Psycho-stimulants for stimulant dependence in the absence of ADHD – Disulfiram for cocaine dependence esp in alcohol drinkers who are willing to stop (not for actively drinking unable / unwilling to stop) Process addictions – Naltrexone

What Doesn’t Work? Anti-depressants for stimulant dependence when depression is not present Dopamine agonists (eg bromocriptine, amantadine, pergolide) or most aed’s for stimulant dependence Disulfiram for alcohol dependence in settings in which daily dosing cannot be assured Naltrexone for opioid dependence in “less motivated” patients SSRI’s in type II (early onset – strong family history) alcoholism – Worse outcomes than placebo Ultra-rapid opioid detox

Thank You to All My Colleagues at Tom Waddell Health Center and Our Many Partners Thank You to My Patients Who I Learn From Every Day